Shopping Cart 0
Cart Subtotal
USD 0

Integrated DNA Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Summary

Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company's products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services such as analytics, custom label, OEM, and packaging and formulation. IDT offers diagnostic tests for genetic and infectious diseases, research to discover new drugs and treatments, and producing agricultural products. The company offers solutions in areas of academic research, biotechnology, and pharmaceutical development. It has operations in Germany, Belgium, Singapore, the UK and the US. IDT is headquartered in Skokie, Illinois, the US.

Integrated DNA Technologies Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Integrated DNA Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 10

Asset Purchase 10

Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 10

Integrated DNA to Acquire Oligonucleotide Business from AITbiotech 11

Private Equity 12

Summit Partners Acquires Minority Stake In Integrated DNA Technologies 12

Partnerships 13

Integrated DNA Enters into Co-Development Agreement with Ubiquitome 13

SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14

RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 15

Licensing Agreements 16

Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 16

Caribou Biosciences Enters into Licensing Agreement with Integrated DNA Technologies for CRISPR-Cas9 Reagents 17

Asset Transactions 18

Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 18

Acquisition 19

Danaher to Acquire Integrated DNA Technologies 19

Integrated DNA Technologies Acquires ValueGene 20

Integrated DNA Technologies Inc-Key Competitors 21

Integrated DNA Technologies Inc-Key Employees 22

Integrated DNA Technologies Inc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Government and Public Interest 24

Aug 06, 2018: Correcting sickle cell-causing mutation with efficient CRISPR-Cas9 genome editing 24

Product News 25

Jun 15, 2017: IDT raises the bar for PCR-based genotyping with novel rhAmp SNP solution 25

Feb 01, 2017: IDT first to market with complete Cpf1-based CRISPR genome editing system 26

Other Significant Developments 27

Mar 13, 2018: IDT supports genomics research with enhanced website 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Integrated DNA Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8


List Of Table

List of Tables

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Integrated DNA Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8

Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 10

Integrated DNA to Acquire Oligonucleotide Business from AITbiotech 11

Summit Partners Acquires Minority Stake In Integrated DNA Technologies 12

Integrated DNA Enters into Co-Development Agreement with Ubiquitome 13

SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14

RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 15

Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 16

Caribou Biosciences Enters into Licensing Agreement with Integrated DNA Technologies for CRISPR-Cas9 Reagents 17

Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 18

Danaher to Acquire Integrated DNA Technologies 19

Integrated DNA Technologies Acquires ValueGene 20

Integrated DNA Technologies Inc, Key Competitors 21

Integrated DNA Technologies Inc, Key Employees 22

Integrated DNA Technologies Inc, Other Locations 23

Integrated DNA Technologies Inc, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com